Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFIX
1901
Stitch Fix
SFIX
$479M
| $11.3M | 0.01% |
354,323
+102,967
| +41% | +$2.76M |
|
1902
Hexcel
HXL
$7.87B
| $11.3M | 0.01% |
140,075
+8,600
| +7% | +$625K |
|
1903
CALL
HubSpot
HUBS
$11.2B
| $11.3M | 0.01% |
66,400
-26,100
| -28% | -$4.56M |
|
1904
Adaptive Biotechnologies
ADPT
$3.94B
| $11.3M | 0.01% |
+234,371
| New | +$10.4M |
|
1905
CALL
Alcoa
AA
$13.2B
| $11.3M | 0.01% |
483,400
-62,400
| -11% | -$1.55M |
|
1906
PUT
Tandem Diabetes Care
TNDM
$1.58B
| $11.3M | 0.01% |
175,200
+10,800
| +7% | +$697K |
|
1907
CALL
Ferrari
RACE
$72.9B
| $11.3M | 0.01% |
70,000
-10,300
| -13% | -$1.48M |
|
1908
PUT
NIO
NIO
$11.3B
| $11.3M | 0.01% |
4,429,900
+2,260,200
| +104% | +$9.07M |
|
|
CERN
1909
CALL
DELISTED
Cerner Corp
CERN
| $11.3M | 0.01% |
154,100
+39,200
| +34% | +$2.64M |
|
1910
Jabil
JBL
$38B
| $11.3M | 0.01% |
357,139
-166,303
| -32% | -$4.77M |
|
|
K
1911
PUT
DELISTED
Kellanova
K
| $11.3M | 0.01% |
224,289
-63,474
| -22% | -$3.37M |
|
1912
Corcept Therapeutics
CORT
$12.4B
| $11.3M | 0.01% |
1,010,466
+859,000
| +567% | +$9.57M |
|
1913
Williams-Sonoma
WSM
$28.4B
| $11.3M | 0.01% |
346,406
+316,508
| +1,059% | +$9.08M |
|
1914
PUT
Conagra Brands
CAG
$7.5B
| $11.3M | 0.01% |
424,200
-262,700
| -38% | -$7.63M |
|
1915
Integra LifeSciences
IART
$1.43B
| $11.3M | 0.01% |
201,436
+79,351
| +65% | +$4.09M |
|
1916
PUT
ProShares Ultra S&P500
SSO
$8.47B
| $11.2M | 0.01% |
712,800
-37,600
| -5% | -$572K |
|
1917
PUT
PVH
PVH
$3.8B
| $11.2M | 0.01% |
118,400
+13,600
| +13% | +$1.5M |
|
|
GLUU
1918
DELISTED
Glu Mobile Inc.
GLUU
| $11.2M | 0.01% |
1,560,275
-1,271,838
| -45% | -$11.7M |
|
1919
Cousins Properties
CUZ
$4.89B
| $11.2M | 0.01% |
309,606
+12,033
| +4% | +$452K |
|
1920
Graco
GGG
$13.3B
| $11.2M | 0.01% |
222,978
+105,720
| +90% | +$5.33M |
|
1921
iShares US Financial Services ETF
IYG
$2.23B
| $11.2M | 0.01% |
250,683
-56,556
| -18% | -$2.48M |
|
1922
CALL
Cencora
COR
$59.9B
| $11.2M | 0.01% |
131,100
+28,500
| +28% | +$2.25M |
|
1923
Madrigal Pharmaceuticals
MDGL
$11.7B
| $11.2M | 0.01% |
106,625
+93,462
| +710% | +$10M |
|
1924
Silgan Holdings
SLGN
$4.49B
| $11.2M | 0.01% |
364,401
+295,534
| +429% | +$8.82M |
|
1925
CALL
Zions Bancorporation
ZION
$10.5B
| $11.2M | 0.01% |
242,500
-268,500
| -53% | -$12.4M |
|
Similar funds
Citadel Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
- Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
- Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.